» Articles » PMID: 18676178

Natural and TGF-beta-induced Foxp3(+)CD4(+) CD25(+) Regulatory T Cells Are Not Mirror Images of Each Other

Overview
Journal Trends Immunol
Date 2008 Aug 5
PMID 18676178
Citations 157
Authors
Affiliations
Soon will be listed here.
Abstract

Foxp3(+) CD4(+) CD25(+) regulatory cell (Treg) subsets that maintain immunologic homeostasis have been considered to be a homogeneous population of naturally occurring, thymus-derived CD4(+)CD25(+) cells (nTregs). However, similar Foxp3+ Tregs can be induced from CD25(-) precursors in vivo, and ex vivo with interleukin 2 (IL-2) and transforming growth factor beta (TGF-beta) (iTregs). These two subsets differ in their principal antigen specificities and in the T-cell receptor signal strength and co-stimulatory requirements needed for their generation. However, whether iTregs have any unique functions in vivo has been unclear. Although IL-6 can convert nTregs to Th17 cells, iTregs induced by IL-2 and TGF-beta are resistant to this cytokine and thereby might retain suppressive function at inflammatory sites. Thus, nTregs and iTregs may have different roles in the adaptive immune response.

Citing Articles

Treg Cell Therapeutic Strategies for Breast Cancer: Holistic to Local Aspects.

Zhang H, Felthaus O, Eigenberger A, Klein S, Prantl L Cells. 2024; 13(18.

PMID: 39329710 PMC: 11429654. DOI: 10.3390/cells13181526.


Targeting tumor-infiltrating tregs for improved antitumor responses.

Qin D, Zhang Y, Shu P, Lei Y, Li X, Wang Y Front Immunol. 2024; 15:1325946.

PMID: 38500876 PMC: 10944859. DOI: 10.3389/fimmu.2024.1325946.


Immunomodulatory effects of canine mesenchymal stem cells in an experimental atopic dermatitis model.

Kang S, Gu N, Byeon J, Hyun B, Lee J, Yang D Front Vet Sci. 2023; 10:1201382.

PMID: 37529178 PMC: 10390254. DOI: 10.3389/fvets.2023.1201382.


Immune Response and Molecular Mechanisms of Cardiovascular Adverse Effects of Spike Proteins from SARS-CoV-2 and mRNA Vaccines.

Bellavite P, Ferraresi A, Isidoro C Biomedicines. 2023; 11(2).

PMID: 36830987 PMC: 9953067. DOI: 10.3390/biomedicines11020451.


COVID-19 immunotherapy: Treatment based on the immune cell-mediated approaches.

Zavvar M, Yahyapoor A, Baghdadi H, Zargaran S, Assadiasl S, Abdolmohammadi K Int Immunopharmacol. 2022; 107:108655.

PMID: 35248946 PMC: 8872837. DOI: 10.1016/j.intimp.2022.108655.